PRDM1 and Miyoshi myopathy: These data suggest that CD93 may indeed be a marker of mature PCs in humans as it is in mice [18] and, furthermore, that a loss of the mature PC markers CD93, BLIMP-1, and the previously reported CXCR4[19], [20] may be predictive of poorer outcome in MM patients.